The prognostic value of metabolic dysfunction-associated steatotic liver disease in acute myocardial infarction: A propensity score-matched analysis.
Gwyneth KongGrace CaoJaycie KohSiew Pang ChanAudrey ZhangEsther WongBryan ChongSilingga Metta JauhariJiong-Wei WangAnurag MehtaGemma A FigtreeMamas A MamasGavin NgKoo Hui ChanPing ChaiAdrian F LowChi Hang LeeTiong Cheng YeoJames YipRoger FooHuay Cheem TanDaniel Q HuangMark MuthiahMark Yan-Yee ChanPoay-Huan LohNicholas W S ChewPublished in: Diabetes, obesity & metabolism (2024)
MASLD embodies a higher burden of metabolic dysfunction and is an independent predictor of long-term mortality in the AMI population. Its early identification may be beneficial for risk stratification and provide therapeutic targets for secondary preventive strategies in AMI.